500.03 Clinical Outcomes of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Stent Versus Standard Drug-Eluting Coronary Stents: A Meta-Analysis
| Autor: | Paul M Ndunda, Zaher Fanari, Mohinder Vindhyal, Tabitha Muutu, Sinan Khayyat |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Drug
medicine.medical_specialty business.industry medicine.medical_treatment media_common.quotation_subject Stent equipment and supplies medicine.disease Dual therapy stent Thrombosis Coronary artery disease surgical procedures operative Restenosis Sirolimus Meta-analysis medicine cardiovascular diseases Radiology Cardiology and Cardiovascular Medicine business medicine.drug media_common |
| Zdroj: | JACC: Cardiovascular Interventions. 12:S39-S40 |
| ISSN: | 1936-8798 |
| DOI: | 10.1016/j.jcin.2019.01.143 |
| Popis: | Clinical outcomes of drug-eluting stents (DES) in coronary artery disease have improved, but concerns about stent neo-atherosclerosis, thrombosis, and restenosis remain. The COMBO dual therapy stent (COMBO DTS) is a sirolimus-eluting stent with CD34 antibodies immobilized on its surface to capture |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|